Real-world retreatment of HCV-infected patients with prior failure to direct acting antiviral therapy using sofosbuvir, velpatasvir and voxilaprevir

被引：0
|
作者：
Smith, David A. [1 ]
Bradshaw, Daniel [2 ]
Mbisa, Jean [2 ]
Manso, Carmen [2 ]
Bibby, David [2 ]
Singer, Josh [3 ]
Thomson, Emma [3 ]
Filipe, Anna da Silva [3 ]
Aranday-Cortes, Elihu [3 ]
Ansari, Azim [1 ]
Brown, Anthony [1 ]
Hudson, Emma [1 ]
Benselin, Jennifer [4 ,5 ]
Healy, Brendan [6 ]
Troke, Phil [7 ]
Mclauchlan, John [3 ]
Barnes, Eleanor [1 ]
Irving, William [4 ,5 ]
机构：
[1] Univ Oxford, Peter Medawar Bldg Pathogen Res, Nuffield Dept Med, Oxford, England
[2] Publ Hlth England, Natl Infect Serv, London, England
[3] Univ Glasgow, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland
[4] Univ Nottingham, Nottingham, England
[5] Nottingham Univ Hosp NHS Trust, Nottingham, England
[6] Univ Hosp Wales, Publ Hlth Wales, Microbiol Cardiff, Cardiff, Wales
[7] Gilead Sci Ltd, London, England
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU402
引用
收藏
页码：S336 / S336
页数：1
相关论文
共 50 条
  • [1] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir in 573 direct-acting antiviral experienced hepatitis C patients
    Belperio, Pamela S.
    Shahoumian, Troy A.
    Loomis, Timothy P.
    Backus, Lisa I.
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (08) : 980 - 990
  • [2] Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
    Graf, Christiana
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Paolucci, Stefania
    Llaneras, Jordi
    Vermehren, Johannes
    Dultz, Georg
    Peiffer, Kai-Henrik
    Finkelmeier, Fabian
    Herrmann, Eva
    Zeuzem, Stefan
    Buti, Maria
    Lampertico, Pietro
    Dietz, Julia
    Sarrazin, Christoph
    JHEP REPORTS, 2024, 6 (03)
  • [3] Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients with prior failure to DAA treatment
    Graf, Christiana
    Degasperi, Elisabetta
    D'Ambrosio, Roberta
    Llaneras, Jordi
    Vermehren, Johannes
    Dultz, Georg
    Wetzstein, Nils
    Herrmann, Eva
    Zeuzem, Stefan
    Buti, Maria
    Lampertico, Pietro
    Dietz, Julia
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2023, 78 : S98 - S99
  • [4] Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices
    Brzdek, Michal
    Zarebska-Michaluk, Dorota
    Kukla, Michal
    Janocha-Litwin, Justyna
    Dybowska, Dorota
    Janczewska, Ewa
    Lorenc, Beata
    Berak, Hanna
    Mazur, Wlodzimierz
    Tudrujek-Zdunek, Magdalena
    Klapaczynski, Jakub
    Piekarska, Anna
    Sitko, Marek
    Laurans, Lukasz
    Parfieniuk-Kowerda, Anna
    Flisiak, Robert
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1114 - 1129
  • [5] REAL-WORLD EFFECTIVENESS OF VOXILAPREVIR/VELPATASVIR/SOFOSBUVIR IN DAA FAILURE PATIENTS: AN INTEGRATIVE ANALYSIS
    Graf, Christiana
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Paolucci, Stefania
    Llaneras, Jordi
    Vermehren, Johannes
    Dultz, Georg
    Peiffer, Kai-Henrik
    Herrmann, Eva
    Zeuzem, Stefan
    Buti, Maria
    Lampertico, Pietro
    Dietz, Julia
    Sarrazin, Christoph
    HEPATOLOGY, 2023, 78 : S739 - S739
  • [6] Effect of Resistance Associated Substitutions on Retreatment of HCV infected patients with prior failure to Direct Acting Antiviral Therapy
    Smith, David
    Bradshaw, Daniel
    Mbisa, Jean
    Manso, Carmen
    Bibby, David
    Singer, Josh
    Thomson, Emma
    Filipe, Ana
    Aranday-Cortes, Elihu
    Ansari, Azim
    Brown, Anthony
    Hudson, Emma
    Benselin, Jennifer
    Healy, Brendan
    Mclauchlan, John
    Barnes, Eleanor
    Irving, William
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E158 - E159
  • [7] Real-World Safety and Effectiveness of Sofosbuvir/Velpatasvir/Voxilaprevir and Glecaprevir/Pibrentasvir in Hepatitis C Infected Patients
    Saxena, Varun
    Chamberland, Scott
    Hurley, Leo
    Lai, Jennifer B.
    Truong, Elizabeth
    Marcus, Julia
    Champsi, Jamila
    Hare, Brad B.
    Korn, Daniel
    Ready, Joanna B.
    Seo, Suk
    Witt, David J.
    Silverberg, Michael J.
    HEPATOLOGY, 2018, 68 : 418A - 419A
  • [8] A systematic review of sofosbuvir/velpatasvir/voxilaprevir in HCV patients previously treated with direct-acting antivirals
    Rustam, Rehan
    Qaisar, Aqsa
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)
  • [9] Efficacy of sofosbuvir/velpatasvir/voxilaprevir in direct-acting antiviral experienced patients with hepatitis C virus
    Da, Ben L.
    Lourdusamy, Vennis
    Kushner, Tatyana
    Dieterich, Douglas
    Saberi, Behnam
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (06) : 859 - 861
  • [10] Final challenges: real-world experience with sofosbuvir, velpatasvir and voxilaprevir in patients with advanced cirrhosis
    Papaluca, Tim
    Roberts, Stuart
    Strasser, Simone
    Stuart, Katherine
    New, Kate
    Farrell, Geoff
    Dore, Gregory
    Wigg, Alan
    Woodward, Aidan
    Wade, Amanda
    George, Jacob
    Sinclair, Marie
    McGarity, Bruce
    Fisher, A. Leslie
    Sawhney, Rohit
    Wilson, Mark
    Valiozis, Ivan
    Levy, Miriam
    Tse, Edmund
    Ahlenstiel, Golo
    Haque, Mazhar
    Prewett, Emily
    Sievert, William
    Sood, Siddharth
    O'Beirne, James
    Thomas, James
    Hazeldine, Simon
    Valaydon, Zina
    Douglas, Mark
    Bowden, Scott
    O'Keefe, Jacinta
    Holmes, Jacinta
    Thompson, Alexander
    JOURNAL OF HEPATOLOGY, 2020, 73 : S363 - S363
12345